Laurion Capital Management LP Bausch Health Companies Inc. Call Options Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $6.99 Million - $23.4 Million	-990,000 Reduced 62.12%	603,600 $5.05 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $34.4 Million - $44.3 Million	1,593,600 New	1,593,600 $36.4 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $412,610 - $635,810	-31,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $77,880 - $181,500	6,000 Added 24.0%	31,000 $481,000
Q2 2019 Aug 13, 2019	SELL	$20.52 - $26.45 $1.85 Million - $2.39 Million	-90,300 Reduced 78.32%	25,000 $631,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $2.38 Million - $2.96 Million	115,300 New	115,300 $2.96 Million

255

254M

5.47M

16.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.17B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.